Clinical problem: There is an absence of data describing the PK of antimicrobials in critically ill adult patients requiring a form of life support called extra-corporeal membrane oxygenation (ECMO).

Generating new knowledge: ASAP-ECMO is a PK Study of patients receiving ECMO (6 ICUs in Australia, New Zealand, South Korea, Switzerland) and will describe the PK of ceftriaxone, meropenem, ciprofloxacin, piperacillin-tazobactam, vancomycin, caspofungin, oseltamivir. 

Capacity building: A/Prof Kiran Shekar (funded by Metro North Fellowship; Mid-Career Researcher MCR1), Ms Vesa Cheng (CRE REDUCE-CRE ACTIONS co-funding; PhD2)

Collaborations: Led by CIA Roberts (NHMRC Fellow; UQ and RBWH) and Prof John Fraser (The Prince Charles Hospital; TPCH)

Funding: Confirmed Intensive Care Foundation, Australia and New Zealand College of Anaesthetists (ANZCA), CRE ACTIONS (led by Prof John Fraser, CIA Roberts is also a CI).

Project members

Dr Mohd Hafiz Abdul-Aziz

Clinical dosing studies workstream lead
Postdoctoral Research Fellow
UQ Centre for Clinical Research